SSY Group Limited (HKG:2005)
Hong Kong
· Delayed Price · Currency is HKD 2.530
+0.020 (0.80%)
Mar 10, 2026, 1:54 PM HKT
SSY Group Revenue
SSY Group had revenue of 2.15B HKD in the half year ending June 30, 2025, a decrease of -35.58%. This brings the company's revenue in the last twelve months to 4.58B, down -29.18% year-over-year. In the year 2024, SSY Group had annual revenue of 5.77B, down -10.67%.
Revenue (ttm)
4.58B
Revenue Growth
-29.18%
P/S Ratio
1.59
Revenue / Employee
803.77K
Employees
5,700
Market Cap
7.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.77B | -689.76M | -10.67% |
| Dec 31, 2023 | 6.46B | 28.98M | 0.45% |
| Dec 31, 2022 | 6.43B | 1.08B | 20.11% |
| Dec 31, 2021 | 5.36B | 1.10B | 25.72% |
| Dec 31, 2020 | 4.26B | -374.78M | -8.08% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Tong Ren Tang Chinese Medicine Company | 1.71B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| China Shineway Pharmaceutical Group | 3.66B |
| China Traditional Chinese Medicine Holdings Co. | 17.08B |
| Edding Genor Group Holdings | 245.46M |
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| Luye Pharma Group | 6.76B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
SSY Group News
- 4 months ago - SSY Group 9-months Profit Falls - Nasdaq
- 5 months ago - SSY Group Secures Approval For Levamlodipine Besilate Tablets For Hypertension Treatment In China - Nasdaq